Search results
BioNTech SE (NASDAQ:BNTX) Shares Sold by Robeco Institutional Asset Management B.V.
ETF DAILY NEWS· 4 days agoRobeco Institutional Asset Management B.V. lowered its position in BioNTech SE (NASDAQ:BNTX – Free Report) by 18.8% in the fourth quarter, HoldingsChannel reports. The fund ...
Investors Buy High Volume of BioNTech Call Options (NASDAQ:BNTX)
ETF DAILY NEWS· 7 days agoBioNTech SE (NASDAQ:BNTX – Get Free Report) was the recipient of some unusual options trading on Wednesday. Traders bought 2,346 call options on the stock
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 18 hours agoSo, all in all, is PFE stock a buy or a sell right now? Pfizer Stock Fundamentals: 'Massive' Upside...
BioNTech (NASDAQ:BNTX) Shares Up 6.1%
ETF DAILY NEWS· 6 days agoBioNTech SE (NASDAQ:BNTX – Get Free Report) shares shot up 6.1% during trading on Wednesday . 657,251 shares were traded during mid-day trading, an increase of 4% from the ...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 6 days agoFurthermore, the company just inked a landmark partnership and licensing deal with French pharmaceutical giant ...workers directly exposed to infected...
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
The Wall Street Journal· 7 days agoModerna, BioNTech, CureVac and Novavax have added billions of dollars in combined market...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 6 days agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Jim Cramer: Celestica Makes A 'Comeback,' Sell This Movie Theater Stock, - Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoJim Cramer called Celestica Inc. "terrific" after the Toronto-based company reported...
Biotech stocks are rising alongside bird flu fears
Semafor via Yahoo Finance· 7 days agoVaccine makers, including Moderna, BioNTech, and CureVac, all saw double-digit stock increases, as investors bet they could cash in on a public health...
Moderna Stock Is Having Another Very Bad Day. Here’s Why.
Barrons.com· 1 day agoThe drop comes as Moderna awaits important developments involving its experimental cancer treatment,...